Bristol-Myers Squibb

About:

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

Website: http://www.bms.com

Twitter/X: BMSNEWS

Top Investors: RA Capital Management, Vivo Capital, Connecticut Innovations, Rock Springs Capital, Aisling Capital

Description:

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. Bristol Myers Squibb focuses on areas such as oncology, cardiovascular, immunoscience, and fibrosis to develop therapies that address significant unmet medical needs. The company's research and development efforts are centered around discovering new drugs and advancing existing ones to improve patient outcomes. BMS has a diverse portfolio of medicines, including several blockbuster drugs used in the treatment of cancer and other diseases. The company is committed to advancing the science of medicine to help people fight serious diseases and improve their quality of life.

Total Funding Amount:

$23.6B

Estimated Revenue Range:

$10B+

Headquarters Location:

New York, New York, United States

Founded Date:

1887-01-01

Founders:

E. R. Squibb, John Ripley Myers, William McLaren Bristol

Number of Employees:

10001+

Last Funding Date:

2024-02-14

IPO Status:

Public

© 2025 bioDAO.ai